简体中文
|
繁體中文
|
English
Home
News
Events
Media Services
About Us
About Interfax
Contact Us
Press Releases
2009-03-03 11:53
AMD to Host a Webcast in Relation to the Closing of The Foundry Company Manufacturing Joint Venture Transaction
2009-03-03 11:21
Clinical Solutions and Apollo Hospitals Partner to Deliver Health Helpline and Telephone Triage Service to India
2009-03-03 11:02
Covidien to Present at Raymond James Conference
2009-02-24 17:37
Pfizer Awards HD Biosciences “2008 Top Research Service Partner”
2009-02-24 17:23
Anritsu Corporation, Japan and Yenista Optics, France Reach Technology Transfer Agreement
2009-02-24 11:48
Bentley’s “Be Employable” Initiative Provides Free Software and Training to Help Sustain Infrastructure Professions
2009-02-24 10:53
Goodrich Signs Flight Hour Agreement with TransAsia to Support Airbus A320 Fleet
2009-02-24 09:51
Tora Reports Significant Growth in Trading Volume, Market Share and Trading Access
2009-02-22 18:00
SpringSoft Agrees to Acquire Certess
2009-02-22 16:50
Lafarge: Notification of Availability of the Management Report for the Year Ended December 31, 2008
<< First
< Previous
2227
2228
2229
2230
2231
2232
2233
2234
2235
2236
Next >
Last >>
68
70
71
30
38
37
36
35
34
11
Weibo
Industries
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2026-10-15 14:56
Responsible AI for Children: IEEE Delivers a Trusted Safety Formula to Help Protect Kids Online
2026-10-15 14:51
Toluna Appoints Amy Fenton as Chief Executive Officer
2026-10-15 14:39
Reliance Foundation and The Estée Lauder Companies Charitable Foundation Launch Multi-Year Partnership That Aims to Empower One Million Girls and Young Women in India
2026-10-15 14:35
Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation
2026-10-15 14:32
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis